Enzo Biochem, Inc. (ENZ)
USD 0.71
(0.73%)
USD 0.71
(0.73%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -26.25 Million | -36.97 Million | -16.59 Million | 387 Thousand | -17.17 Million | 4.8 Million |
| Net Income | -26.07 Million | 20.28 Million | -18.26 Million | 7.87 Million | -28.52 Million | 2.48 Million |
| Depreciation & Amortization | 1.27 Million | 2.68 Million | 2.82 Million | 2.65 Million | 2.78 Million | 3.03 Million |
| Deferred income taxes | - | -5.85 Million | - | - | - | - |
| Stock-based compensation | 2.29 Million | 3.14 Million | 2.33 Million | 1.63 Million | 1.76 Million | 1.79 Million |
| Change in working capital | -8.25 Million | 18.55 Million | -6.83 Million | -4.77 Million | 7.95 Million | -3 Million |
| Other non-cash items | 4.5 Million | -75.79 Million | 3.34 Million | -7 Million | -1.16 Million | 493 Thousand |
| Investing Cash Flow | -545 Thousand | 98.98 Million | 25.22 Million | -34.49 Million | -2.17 Million | -8.12 Million |
| Investments in PPE | -545 Thousand | -2.76 Million | -3.47 Million | -4.43 Million | -2.17 Million | -8.12 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | 28.69 Million | -30.06 Million | - | - |
| Sales/Maturities of investments | - | - | 28.69 Million | - | - | - |
| Other Investing Activities | -545 Thousand | 101.74 Million | -28.69 Million | -30.06 Million | - | - |
| Financing Cash Flow | -4.19 Million | -1.12 Million | -241 Thousand | -242 Thousand | 7 Million | 4.19 Million |
| Debt repayment | -3.71 Million | -24.98 Million | -269 Thousand | -339 Thousand | -411 Thousand | -404 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 386 Thousand | 28 Thousand | 97 Thousand | - | 167 Thousand |
| Other Financing Activities | -474 Thousand | 23.47 Million | -241 Thousand | -242 Thousand | 7.41 Million | 4.43 Million |
| Accounts receivables | 2.47 Million | 5.03 Million | -1.29 Million | -1.11 Million | 1.61 Million | 2.4 Million |
| Accounts payables | -7.73 Million | 1.15 Million | 390 Thousand | -395 Thousand | 1.21 Million | -2.5 Million |
| Inventory | 1.09 Million | -334 Thousand | -2.73 Million | -4.93 Million | 85 Thousand | -572 Thousand |
| Other working capital | -4.08 Million | -5.85 Million | -3.19 Million | 1.66 Million | 5.04 Million | -2.33 Million |
| Cash at beginning of period | 83.37 Million | 22.6 Million | 14.27 Million | 48.61 Million | 60.89 Million | 60.04 Million |
| Cash at end of period | 52.37 Million | 83.37 Million | 22.6 Million | 14.27 Million | 48.61 Million | 60.89 Million |
| Capital Expenditure | -545 Thousand | -2.76 Million | -3.47 Million | -4.43 Million | -2.17 Million | -8.12 Million |
| Effect of forex changes on cash | -5000.00 | -109 Thousand | -63 Thousand | 11 Thousand | 67 Thousand | -18 Thousand |
| Net cash flow / Change in cash | -31 Million | 60.77 Million | 8.32 Million | -34.34 Million | -12.28 Million | 855 Thousand |
| Free Cash Flow | -26.8 Million | -39.73 Million | -20.06 Million | -4.04 Million | -19.34 Million | -3.32 Million |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -13.38 Million | -2.13 Million | -863 Thousand | -6.61 Million | 20.28 Million | 57.43 Million |
| Depreciation & Amortization | 398 Thousand | 337 Thousand | 267 Thousand | 270 Thousand | 2.68 Million | 606 Thousand |
| Deferred income taxes | - | - | -3.54 Million | 970 Thousand | -5.85 Million | - |
| Stock-based compensation | 259 Thousand | 339 Thousand | 514 Thousand | 1.18 Million | 3.14 Million | 868 Thousand |
| Change in working capital | 8.43 Million | -1.42 Million | -5.75 Million | -9.51 Million | 18.55 Million | 4.63 Million |
| Other non-cash items | 3.2 Million | -78 Thousand | 448 Thousand | 328 Thousand | -75.79 Million | -80.57 Million |
| Investing Cash Flow | -123 Thousand | -143 Thousand | -25 Thousand | -254 Thousand | 98.98 Million | 101.16 Million |
| Investments in PPE | -123 Thousand | -143 Thousand | -25 Thousand | -254 Thousand | -2.76 Million | -573 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -123 Thousand | -143 Thousand | - | - | 101.74 Million | 101.74 Million |
| Financing Cash Flow | -3.6 Million | -44 Thousand | -22 Thousand | -518 Thousand | -1.12 Million | -4.24 Million |
| Debt repayment | -3.6 Million | -37 Thousand | -22 Thousand | -51 Thousand | -24.98 Million | -20.51 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -7000.00 | - | -467 Thousand | - | - |
| Common Stock Issuance | - | - | - | - | 386 Thousand | 386 Thousand |
| Other Financing Activities | - | -7000.00 | - | -467 Thousand | 23.47 Million | 15.89 Million |
| Accounts receivables | 2000.00 | 1.22 Million | -767 Thousand | 2.01 Million | 5.03 Million | 3.17 Million |
| Accounts payables | -83 Thousand | -557 Thousand | -1.49 Million | -5.6 Million | 1.15 Million | -3.96 Million |
| Inventory | 454 Thousand | 444 Thousand | -236 Thousand | 428 Thousand | -334 Thousand | -425 Thousand |
| Other working capital | 8.06 Million | -2.53 Million | -3.25 Million | 3.15 Million | -5.85 Million | 5.85 Million |
| Cash at beginning of period | 57.15 Million | 65.24 Million | 74.2 Million | 83.37 Million | 22.6 Million | 3.63 Million |
| Cash at end of period | 52.37 Million | 62.15 Million | 65.24 Million | 69.2 Million | 83.37 Million | 83.37 Million |
| Capital Expenditure | -123 Thousand | -143 Thousand | -25 Thousand | -254 Thousand | -2.76 Million | -573 Thousand |
| Effect of forex changes on cash | 32 Thousand | -36 Thousand | 19 Thousand | -20 Thousand | -109 Thousand | -155 Thousand |
| Net cash flow / Change in cash | -4.78 Million | -3.08 Million | -8.96 Million | -14.16 Million | 60.77 Million | 79.74 Million |
| Free Cash Flow | -1.2 Million | -3 Million | -8.96 Million | -13.62 Million | -39.73 Million | -17.6 Million |
0628
GL1
LRH
NEXPF
BHFAL
BOSSY